Zevra Therapeutics Inc
US ˙ NASDAQ ˙ US4884451075
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityKMPH / Zevra Therapeutics Inc
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in KMPH / Zevra Therapeutics Inc

On April 28, 2020 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Zevra Therapeutics Inc (US:KMPH) valued at $0 USD as of March 31, 2020. The entity filed a previous 13F-HR on February 5, 2020 disclosing 100 shares of Zevra Therapeutics Inc. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (KMPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 23,300 of underlying shares valued at $217,156 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KMPH / Zevra Therapeutics Inc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2020-04-28 2020-03-31 13F KEMPHARM COM 488445107 0 -100 -100.00 0 -100.00 0.0000
2020-02-05 2019-12-31 13F KEMPHARM COM 488445107 100 -170 -62.96 0 0.0000
2019-10-15 2019-09-30 13F KEMPHARM COM 488445107 270 270 0 0.0000
2019-07-26 2019-06-30 13F KEMPHARM COM 488445107 0 -16,150 -100.00 0 -100.00
2019-04-18 2019-03-31 13F KEMPHARM COM 488445107 16,150 14,589 934.59 26 1,200.00 0.0001
2019-01-16 2018-12-31 13F KEMPHARM COM 488445107 1,561 -11,213 -87.78 2 -96.72 0.0000
2018-10-23 2018-09-30 13F KEMPHARM COM 488445107 12,774 12,774 718.32 61 2,950.00 0.0002
2018-04-26 2018-03-31 13F KEMPHARM COM 488445107 0 -107 -100.00 0 0.0000
2018-01-10 2017-12-31 13F KEMPHARM COM 488445107 107 107 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-10-15 2019-09-30 13F KEMPHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-07-26 2019-06-30 13F KEMPHARM CALL Call 177 268.75 30 275.00 n/a n/a n/a
2019-04-18 2019-03-31 13F KEMPHARM CALL Call 48 -72.88 8 -73.33 n/a n/a n/a
2018-10-23 2018-09-30 13F KEMPHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-07-30 2018-06-30 13F KEMPHARM CALL Call 2 100.00 1 n/a n/a n/a
2018-04-26 2018-03-31 13F KEMPHARM CALL Call 1 0 n/a n/a n/a
2017-10-25 2017-09-30 13F KEMPHARM CALL Call 0 -100.00 0 n/a n/a n/a
2017-07-12 2017-06-30 13F KEMPHARM CALL Call 2 0.00 0 n/a n/a n/a
2017-04-21 2017-03-31 13F KEMPHARM CALL Call 2 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ZEVRA THERAPEUTICS PUT Put 23,300 -22.33 217 -19.03 n/a n/a n/a
2026-02-11 2025-12-31 13F ZEVRA THERAPEUTICS PUT Put 30,000 36.99 269 n/a n/a n/a
2025-11-12 2025-09-30 13F ZEVRA THERAPEUTICS PUT Put 21,900 39.49 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ZEVRA THERAPEUTICS PUT Put 15,700 12.95 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ZEVRA THERAPEUTICS PUT Put 13,900 -39.04 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ZEVRA THERAPEUTICS PUT Put 22,800 5.07 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ZEVRA THERAPEUTICS PUT Put 21,700 85.47 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ZEVRA THERAPEUTICS PUT Put 11,700 -53.57 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ZEVRA THERAPEUTICS PUT Put 25,200 -84.13 0 -100.00 n/a n/a n/a
2024-02-02 2023-12-31 13F ZEVRA THERAPEUTICS PUT Put 158,800 0.57 1 n/a n/a n/a
2023-11-01 2023-09-30 13F ZEVRA THERAPEUTICS PUT Put 157,900 -8.68 1 n/a n/a n/a
2023-08-04 2023-06-30 13F ZEVRA THERAPEUTICS PUT Put 172,900 -24.43 1 -100.00 n/a n/a n/a
2023-04-27 2023-03-31 13F ZEVRA THERAPEUTICS PUT Put 228,800 -49.10 1 -50.00 n/a n/a n/a
2023-02-02 2022-12-31 13F KEMPHARM PUT Put 449,500 -4.54 2 -99.93 n/a n/a n/a
2022-11-04 2022-09-30 13F KEMPHARM PUT Put 470,900 29.69 2,938 81.47 n/a n/a n/a
2022-08-03 2022-06-30 13F KEMPHARM PUT Put 363,100 116.39 1,619 91.82 n/a n/a n/a
2022-05-02 2022-03-31 13F KEMPHARM PUT Put 167,800 -20.66 844 -54.18 n/a n/a n/a
2022-02-23 2021-12-31 13F/A KEMPHARM PUT Put 211,500 1,605.65 1,842 1,016.36 n/a n/a n/a
2022-02-04 2021-12-31 13F KEMPHARM PUT Put 12,400 165 n/a n/a n/a
2021-10-28 2021-09-30 13F KEMPHARM PUT Put 12,400 4.20 165 8.55 n/a n/a n/a
2021-08-12 2021-06-30 13F KEMPHARM PUT Put 11,900 5,704.88 152 -19.15 n/a n/a n/a
2021-04-26 2021-03-31 13F KEMPHARM PUT Put 205 -98.28 188 23.68 n/a n/a n/a
2020-04-28 2020-03-31 13F KEMPHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-05 2019-12-31 13F KEMPHARM PUT Put 1 0 n/a n/a n/a
2019-07-26 2019-06-30 13F KEMPHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-04-18 2019-03-31 13F KEMPHARM PUT Put 263 1,778.57 43 2,050.00 n/a n/a n/a
2019-01-16 2018-12-31 13F KEMPHARM PUT Put 14 -94.68 2 -95.35 n/a n/a n/a
2018-04-26 2018-03-31 13F KEMPHARM PUT Put 0 -100.00 0 n/a n/a n/a
2018-01-10 2017-12-31 13F KEMPHARM PUT Put 3 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.